High novelty-seeking has been related to an increased risk for developing addiction, but the neurobiological mechanism underlying this relationship is unclear. We investigated whether differences in dopamine (DA) D 2/3 -receptor (D 2/3 R) function underlie phenotypic divergence in novelty-seeking and vulnerability to addiction. Measures of D 2/3 R availability using the D 2 R-preferring antagonist [ viours were used to characterize DA signalling in Roman high-(RHA) and low-avoidance (RLA) rats, which respectively display high and low behavioural responsiveness both to novelty and psychostimulant exposure. When compared to RLA rats, high novelty-responding RHAs had lower levels of D 2 R, but not D 3 R, binding and mRNA in substantia nigra/ventral tegmental area (SN/VTA) and showed behavioural evidence of D 2 -autoreceptor subsensitivity. RHA rats also showed a higher expression of the tyrosine hydroxylase gene in SN/VTA, higher levels of extracellular DA in striatum and augmentation of the DA-releasing effects of amphetamine (Amph), suggesting hyperfunctioning of midbrain DA neurons. RHA rats also exhibited lower availabilities and functional sensitivity of D 2 R, but not D 3 R, in striatum, which were inversely correlated with individual scores of novelty-seeking, which, in turn, predicted the magnitude of Amph-induced behavioural sensitization. These results indicate that innately low levels of D 2 R in SN/VTA and striatum, whether they are a cause or consequence of the concomitantly observed elevated DA tone, result in a specific pattern of DA signalling that may subserve novelty-seeking and vulnerability to drug use. This suggests that D 2 R deficits in SN/VTA and striatum could both constitute neurochemical markers of an addiction-prone phenotype.
Introduction
One challenge in addiction research is to determine the physiological processes that underlie individual vulnerability to addiction in order to develop therapeutic strategies targeting people who use drugs occasionally but are at risk for addiction. It has been proposed that the personality trait of novelty-seeking may predict the risk for addiction in humans (Bardo et al., 2007) . Interestingly, positron emission tomography (PET) imaging studies have revealed deficits in dopamine (DA) D 2/3 -receptor (D 2/3 R) in the midbrain of novelty-seekers (Zald et al., 2008) and in striatum of psychostimulant-addicted subjects (Volkow et al., 1993) . These human studies suggest that the noveltyseeking temperament and the individual vulnerability to drug addiction may be related to D 2/3 R deficits. However, it is difficult to disentangle in drug users whether D 2/3 R deficits predate the onset of drug use or represent a neuroadaptative response to chronic intake, as chronic psychostimulant exposure by itself can produce a decrease in striatal D 2/3 R availability (Ginovart et al., 1999) .
A preclinical model that provides divergent noveltyseeking and drug-sensitivity profiles is the Swiss sublines of Roman high-(RHA/Verh) and low-(RLA/Verh) avoidance rats. RHA rats have been described as high novelty-responders when compared with their RLA counterparts (Steimer et al., 1998; Escorihuela et al., 1999) . The repeated administration of psychostimulant drugs, including amphetamine (Amph), to RHA rats produces a progressive and enduring increase in drug-induced DA release in the nucleus accumbens (NAcc) and in the psychomotor response to these drugs (see review in Giorgi et al., 2007) . In contrast, the low novelty-seeker RLA rats appeared quite resistant to the neurochemical and behavioural sensitizing effects of psychostimulants (see review in Giorgi et al., 2007) . As drug sensitization is believed to play a critical role in the development of addiction (Robinson and Berridge, 1993) , the RHA and RLA rat lines may serve as suitable models to investigate the neurobiological basis of individual differences in novelty-seeking and its corollary vulnerability to addiction.
We investigated the DA D 2/3 R neurotransmission system in RHA and RLA rats using a combination of neurochemical, molecular and behavioural approaches. Regional brain D 2/3 R availabilities were evaluated using [ 18 F]Fallypride, a D 2 R-preferring antagonist PET radiotracer (Mukherjee et al., 1999) , and [ 3 H]-(+)-PHNO, a D 3 R-preferring agonist (Freedman et al., 1994) and tritiated analogue of the PET radiotracer [
11 C]-(+)-PHNO (Wilson et al., 2005) . The use of PET radiotracers in the present rodent study will provide the foundation for future imaging studies in humans to investigate relationships between individual differences in D 2/3 R availability and behavioural phenotypes related to sensation-seeking and drug addiction. Polymerase chain reaction (PCR) was used to determine levels of several dopaminergic-related genes [(D 2 R, D 3 R and the rate-limiting enzyme in DA biosynthesis tyrosine hydroxylase (TH)]. The effects of the preferential D 2 R-agonist quinpirole and D 3 R-agonist PD128907 on locomotion were then recorded to assess functional D 2/3 R sensitivity. Finally, we tested whether individual differences in noveltyseeking temperament are related to D 2 R availability in striatum and to Amph-induced behavioural sensitization. Our data suggest that a presynaptic hyperdopaminergic state combined with a decreased function of post-synaptic D 2 R may contribute to the establishment of a predisposed phenotype sensitive to novelty and addiction.
Materials and method

Animals and drugs
Male RHA/Verh (RHA) and RLA/Verh (RLA) rats, aged 5 months, were housed in a 12:12 h light-dark cycle (lights on 08:00 hours) with food and water ad libitum. Amph and reserpine were obtained from Sigma-Aldrich (Switzerland) and PD128907 and quinpirole hydrochloride from Tocris (UK euthanized by decapitation and their brains quickly removed. A series of three 30 μM-thick adjacent sections, taken at 150 μM intervals, were immediately cut with a cryostat. Sections were selected to cover most of the caudo-rostral extension of the caudate/putamen (CPu), NAcc, substantia nigra (SN) and ventral tegmental area (VTA). The first section was stained for acetylcholinesterase and used as histological reference. The second section was exposed onto γ-sensitive phosphor-imaging plates (BAS-IP MS2325; Fuji, Japan) overnight to reveal the brain distribution of [
18 F]Fallypride. The third section was exposed onto 3 H-sensitive phosphor-imaging plates (BAS-TR2025) for 4 wk to reveal the brain distribution of
Autoradiograms were analysed with the Fujifilm BAS-1800II phosphorimager system using Aida Software V4.06 (Raytest Isotopenmessgeräte GmbH, Germany). Regions of interest (ROIs) were delineated on histological references and transferred onto adjacent autoradiographic sections. Background film signal values were subtracted from the ROI signal and a mean radioactivity value was calculated for each ROI. Ex vivo binding of radioligands in target ROIs was quantified using a specific binding ratio (SBR), which is defined as SBR = (ROI-cerebellum)/cerebellum and where the cerebellum is used to estimate free and non-specifically bound radiotracers.
Real-time PCR
Fourteen rats per line were euthanized by decapitation, their brain quickly removed and frozen at −25°C. Brains were cut serially into 300 μM-thick coronal sections using a cryostat. A 1.5-mm diameter stainlesssteel puncher was used to punch out from section tissue samples for the CPu, NAcc and SN/VTA. Tissue punches and the tissue remaining in sections, which was to be used as calibrator, were preserved at −80°C until use.
Each individual tissue punch was assayed for D 2 R, D 3 R and for TH mRNAs. Total RNA were isolated with Accuzol reagent (Labgene Scientific, Switzerland) and treated with Turbo DNAse (Ambion, Switzerland). RNA quality and yield were assessed by spectrophotometry (Biophometer plus; Eppendorf, Germany) and stored at −80°C. Reverse-transcriptions were performed with total RNA (1 μg) using a cDNA synthesis kit (Bioline, Switzerland) with random hexamer (130 ng) and oligos dT (25 ng). All quantitative real-time PCR reactions were carried out in duplicate on Rotor-Gene 6000 (Corbett, Qiagen, The Netherlands) according to the Kapa SYBR Green Fast protocol (Kapa Biosystems, Labgene Scientific, Switzerland). Thermal cycler conditions were 3 min at 95°C followed by 45 cycles of 5 s at 95°C, 20 s at 60°C and 2 s at 72°C. Primer (Microsynth AG, Switzerland) sets were designed using the Universal Probe Library (Roche Applied Science, Germany) and evaluated using linear regression analysis. Primer characteristics are given in Table 1 . Samples were quantified by the ΔΔCT method with efficiency correction (Pfaffl, 2001 ) using the calibrator tissue and a reference gene (GAPDH).
Effect of acute Amph and reserpine on [
18 F]Fallypride
and [ 3 H]-(+)-PHNO bindings
In vivo radioligand binding to D 2/3 R is sensitive to competition with endogenous DA (see review in Ginovart, 2005) . Increasing extracellular DA with Amph leads to a reduction in radioligand binding to D 2/3 R that allows estimating the magnitude of Amph-induced DA release. Conversely, decreasing DA competition with DA-depleting agents increases radioligand binding to D 2/3 R and allows the estimation of DA-induced occupancy of D 2/3 R at basal conditions. Twelve rats from each line were divided into two groups, each receiving an i.v. injection of either Amph (1.5 mg/kg; n = 6 per line) or saline (n = 6 per line) 30 min prior to an i.v. injection of 17.6 ± 1.7 MBq [ 18 F]Fallypride (SR = 117 ± 8 Gbq/μmol). In addition, 14 rats from each line received an i.p. injection of either reserpine (1 mg/kg; n = 8 per line) or saline (n = 6 per line) 24 h prior to an i.v. injection of 16.5 ± 1.1 MBq [
18 F]Fallypride (SR = 145 ± 7 Gbq/μmol). This dose of reserpine was chosen so as to cause a near complete (78-87%) depletion of striatal DA content at 24 h post injection (Menzaghi et al., 1997; Wacan et al., 2006 with 1.5 ml solvable (PerkinElmer, Switzerland), added with 5.5 ml Aquassure scintillation fluid (PerkinElmer). After a further 48 h of shaking, samples were counted in a β-counter. Regional radioactivity was expressed as a percentage of the injected dose/g tissue weight (%ID/g). Specific binding was estimated by the SBR, defined as SBR = (%ID/g striatum -%ID/g cerebellum)/(%ID/g cerebellum).
Effects of acute DA agonists on locomotor activity Locomotor recordings were used to test the behavioural responsiveness of RHA and RLA rats to direct-acting DA agonists. The locomotor apparatus was a transparent 48 × 48 × 40 cm open field (ActiMot, TSE Systems, Germany) that contained two rows of 16 photocell beams to measure horizontal activity. Locomotor responses to the D 3 R-preferring agonist PD128907 and to the D 2 R-preferring agonist quinpirole were tested over three consecutive days in the same animals (n = 16 per line). Animals were i.p. injected with either PD128907 (0.2 mg/kg; n = 8 per line) or saline (n = 8 per line) on the first day. Immediately after the injection, animals were placed in the open field and their locomotor activity recorded for 90 min. On the second day, rats were i.p. injected with saline and their locomotor activity monitored for 90 min to confirm no carry-over effect of PD128907 on locomotion. On the third day, rats received an i.p. injection of quinpirole (0.5 mg/kg) or saline and their locomotor activity was monitored for 90 min.
To test the effects of post-synaptic D 2 R stimulation by quinpirole on locomotor activity, two other cohorts of animals were used (n = 8 per line) and tested on two consecutive days. On each experimental day, animals were first placed in the open field for 50 min of habituation. Rats then received an i.p. injection of either saline (day 1) or quinpirole (0.5 mg/kg; day 2) and were monitored for an additional 120 min. Horizontal locomotor activity was calculated as the distance travelled (m) in 10-min blocks or for the entire post-drug injection time period.
Locomotor response to a sensitizing regimen of Amph
To assess their susceptibility to develop behavioural sensitization to chronic psychostimulant administration, RHA and RLA rats were treated with Amph, according to a sensitizing paradigm previously described (Tenn et al., 2003) . Rats (n = 7-8 per line) received i.p. injections of Amph on Monday, Wednesday and Friday for 3 wk for a total of nine injections. On the first and second weeks, animals received three injections at 1 and 2 mg/kg, respectively. On the third week, animals received two injections of 3 mg/kg and the last injection of 1 mg/kg. In each animal, the locomotor response to the first (i.e. acute) and to the last (i.e. ninth) injection of this Amph treatment regimen was measured. On each occasion, rats were first allowed to habituate to the open field for 45 min. Rats were then injected with saline as a mild stressor and their activity was recorded for 30 min. Animals were then injected with Amph (1 mg/kg) and their activity measured for an additional 60 min.
Concurrent measurement of novelty-seeking and [ 3 H]-(+)-PHNO brain uptake
Novelty-seeking was measured by recording headdipping activity in a hole-board (File and Wardill, 1975) . The apparatus consisted of a 48 × 48 × 40 cm open field containing eight holes (diameter: 3.7 cm) in the floor where different objects were placed (plastic tube, sponge, sawdust, etc.). Head dipping was measured as the number of interruptions of infrared beams located under the holes using a photocell activity monitor (TSE Systems, Germany). In this experiment, animals (n = 6 per line) were injected with 0. RLA rats at baseline (Fig. 2c) . In marked contrast to 
RHA rats exhibit higher D 3 R and lower D 2 R and TH gene expression than RLAs
Comparisons of the relative expression of the D 2 R, D 3 R and TH genes in different brain regions of RHA and RLA rats are shown in Fig. 3 . D 3 R gene expression in CPu was higher in RHA than in RLA rats (+41.4%; p = 0.02). Importantly, higher levels of TH mRNA (+38.2%; p = 0.026) together with lower levels of D 2 R mRNA (−37.4%; p = 0.006) were observed in SN/VTA of RHA when compared to RLA rats. Novelty-seeking, drug sensitization and D 2/3 R 1823 RHA rats exhibit higher reduction of [ Fig. 5a ) manner. The main effect of line was significant (F 1,252 = 8.85; p = 0.003) and timedependent (F 8,252 =1.98; p = 0.048) with higher locomotor values in saline-RHA than in saline-RLA rats during the first 10 min of recordings (p = 0.0001). Post hoc analysis showed that the PD128907-induced decrease in locomotion was restricted to the first 20 and 30 min of behavioural testing in RLA and RHA rats, respectively. When data were binned over the first 30 min of testing and compared with the respective salinetreated control data (Fig. 5b) , PD128907 caused reductions in locomotor activity that were similar (p = 0.362) between RHAs (−67.4%; p = 0.0003) and RLAs (−62.5%; p = 0.004).
Confirming no carry-over of PD128907, locomotor activity recorded on the subsequent day following a saline injection was not affected by treatment (F 1,252 = 0.36; p = 0.56) but was influenced both by time (F 8,252 = 40.56; p = 0.0001) and line (F 1,252 = 14.71; p = 0.0001; Fig. 5c,d ). Post hoc analysis again showed higher locomotion in RHA than in RLA rats during the first 10 min of recordings (p = 0.022).
Quinpirole induced an initial suppressive effect on locomotion, an effect likely reflecting the activation of presynaptic D 2 -autoreceptors (D 2 -autoR; Eilam and Szechtman, 1989 ). There was a main effect of quinpirole on locomotor activity (F 1,250 = 63.86; p = 0.0001) that was both time-(F 8,250 = 18.63; p = 0.0001) and line-(F 1,250 = 4.23; p < 0.05 = 0.041; Fig. 5e ) dependent. A significant line× time effects interaction (F 8,250 = 2.35; p = 0.018) was observed, with a higher locomotor activity in saline-RHAs than in saline-RLAs during the first 10 min of recording (p = 0.007). Post hoc analysis revealed that quinpirole reduced locomotion in the first 30 min of recordings in both RLA and RHA rats. When data were binned over the 30 min post-injection time period and compared with the respective control data, quinpirole caused lower reductions (p = 0.04; Fig. 5f ) in locomotor activity in RHAs (−77.3%; p = 0.0001) than in RLAs (−84.9%; p = 0.0001).
RHA rats are hyposensitive to the post-synaptic effect of quinpirole As quinpirole is known to induce a late increase in locomotion likely through activation of post-synaptic D 2 R (Eilam and Szechtman, 1989) , spontaneous locomotor activity of RHA and RLA rats was first monitored for 50 min of habituation and then for Significantly different from RLA rats at * p < 0.05, ** p < 0.01, using an unpaired Student's t test.
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Quinpirole affected locomotion (F 1,476 = 5.21; p = 0.022) in a line-(F 1,476 = 7.35; p = 0.007) and time-(F 16,476 = 5.61; p = 0.0001) dependent manner. Post hoc analysis revealed that quinpirole significantly increased locomotion above saline control levels in RLAs between 80 and 120 min post-injection, whereas locomotor activity was stimulated at only 120 min post-injection in RHAs (Fig. 6a) . When data were binned over the 120 min post-injection time period and compared with the respective saline control data, quinpirole increased locomotor activity in RLA (+49%; p = 0.047) but not in RHA (p = 0.103) rats. Significantly different from the respective saline-treated group at † p < 0.05, † † p < 0.01, and significantly different from RLA rats at * p < 0.05, *** p < 0.001, using a two-way analysis of variance followed by a LSD post hoc test.
Considering only the late effect (60-120 min postinjection; Fig. 6b ), quinpirole activated locomotion in both RHA (+86%, p = 0.03) and RLA (+164%, p = 0.0013) rats, but this effect was lower in RHAs than in RLAs (p = 0.018).
RHA rats show a behavioural supersensitivity to chronic Amph administration
One index of behavioural sensitization to Amph is provided by a within-subjects comparison of the psychomotor stimulant effect of the drug on the first day vs. the last day of drug treatment. When measuring the psychomotor effect of the first (acute) injection of Amph in RHAs and RLAs, ANOVA analysis revealed main effects of line (F 1,252 = 28.33; p = 0.0001) and time (F 8,252 = 36.6; p = 0.0001) on locomotion. The first Amph injection increased locomotor activity from 30 to 60 min post-injection in RLA rats (Fig. 7a) and from 15 to 60 min post-injection in RHA rats (Fig. 7b) . However, when data were binned over the 60 min post-Amph time period, locomotor activity in RLAs (336 ± 66 m) was not significantly different from that of RHAs (416 ± 90 m), indicating that both lines were equally sensitive to the psychomotor-activating effect of an acute administration of Amph. When injected for the ninth time, Amph elicited a locomotor response that was different from the response elicited by the first Amph injection (F 1,252 = 12.09; p = 0.0006) and this effect was line-(F 1,252 = 4.02; p = 0.046) and time-(F 8,252 = 2.81; p = 0.005) dependent (Fig. 7a, b) . There was no difference in the locomotor response of RLA rats to the ninth Amph injection when compared to the first injection (p = 0.33; Fig. 7a ), indicating a lack of sensitization to the hyperlocomotor effect of Amph in RLA rats. In contrast, the ninth Amph injection produced a greater locomotor response than the first injection in RHA rats (p = 0.003; Fig. 7b ), indicating that these rats did sensitize to the drug. When data were binned over the 60 min post-injection time period, the psychomotorstimulant effect of the ninth vs. the first Amph injection was significantly increased in RHA (+77.3%; p = 0.003) but not in RLA (+25%; p = 0.33) rats (Fig. 7c) . Interestingly, the amplitude of the locomotor response to novelty, as measured during the 45 min preceding the first injection of Amph, correlated significantly with subsequent behavioural sensitization to Amph (r = 0.62, p = 0.013; Fig. 7d Significantly different from the respective saline-treated group at † p < 0.05, † † p < 0.01, † † † p < 0.001 and significantly different from RLA rats at * p < 0.05, ** p < 0.01, *** p < 0.001, using a three-way analysis of variance followed by a LSD post hoc test.
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showed that RHA rats made a greater number of head dips (+80%, p = 0.009; Fig 8a) and displayed lower striatal Fig. 8c ), suggesting that novelty-seeking is inversely related to the apparent availability of striatal D 2 R.
Discussion
The present study provides evidence that deficits in D 2 R signalling in SN/VTA and striatum are associated with high novelty-seeking and enhanced susceptibility to develop addiction-related behaviours in RHA rats. RHA rats exhibited lower levels of D 2 R binding and mRNA in SN/VTA than RLAs, suggesting a lower D 2/3 R-mediated autoinhibitory control of DA neurons in the former line. Consistent with this hypothesis, RHA rats were hyposensitive to the suppressive locomotor effect of quinpirole, an effect that is attributed to activation of presynaptic D 2 R (Eilam and Szechtman, 1989) . Relative to RLAs, RHA rats also showed higher levels of TH gene expression in SN/VTA, higher basal levels of extracellular DA in striatum and higher DA release in response to Amph.
All together, these observations concur to indicate a subsensitivity of midbrain D 2 -autoR functioning likely underlying a presynaptic hyperdopaminergic state in RHA rats. In addition to those presynaptic differences, RHA rats exhibited lower levels of D 2 R in striatum and a blunted hyperlocomotor response to quinpirole, indicating a decreased function of post-synaptic D 2 R when compared to RLAs. RHAs also showed a high proneness to Amph sensitization and high reactivity to novelty that was directly associated with lower levels of striatal D 2 R. Such between-line differences in dopaminergic function may contribute to the divergent phenotypic traits observed between RHA and RLA rats, in particular those related to novelty-seeking and vulnerability to addiction. Collectively, our data suggest that a high presynaptic DA tone in combination with low post-synaptic D 2 R signalling may contribute to the establishment of a predisposed phenotype for attributing enhanced motivation for drug and natural rewards and thus conferring vulnerability to addiction.
Novelty-seeking is one of the most widely studied personality traits in relation to vulnerability to drug abuse. Consistent with previous observations (Steimer et al., 1998; Escorihuela et al., 1999) , RHA rats showed higher levels of exploratory behaviour when confronted with a novel environment both in the open-field and hole-board tests, indicating higher Significantly different from the respective saline-treated group at † p < 0.05, † † p < 0.01, † † † p < 0.001 and significantly different from RLA rats at * p < 0.05, using a three-way ANOVA followed by a LSD post-hoc test.
novelty-seeking in RHAs than in RLAs. RHA rats also showed lower levels of [ Significantly different when compared to data obtained during the 60-75 min time interval preceding Amph administration at ∫p < 0.05, ∫∫p < 0.01, ∫∫∫p < 0.001; significantly different from the respective Amph-naive group at † p < 0.05, † † p < 0.01, and significantly different from the respective RLA group at * p < 0.05, ** p < 0.01, *** p < 0.001, using a three-way analysis of variance followed by a LSD post hoc test.
D 2 -autoR availability in humans (Zald et al., 2008) and to high firing and bursting activity of midbrain DA neurons in rodents (Marinelli and White, 2000) . Moreover, the observation that high noveltyresponsive RHA rats exhibited a greater release of striatal DA following Amph substantiates the view that D 2 -autoR subsensitivity confers greater dopaminergic reactivity to stimuli. Similarly, novelty- (Leyton et al., 2002) and sensation- (Riccardi et al., 2006) (Giorgi et al., 1997; Lecca et al., 2004) but also in response to novelty (Rebec, 1998; Saigusa et al., 1999) . D 2 -autoR is an important component of inhibitory control of the mesostriatal system that normally assigns incentive salience to reward-related stimuli and motivates goal-directed behaviours (Robinson and Berridge, 1993) . Excessive DA signalling due to a loss of that inhibitory control could lead to the attribution of exaggerated salience to reward-associated stimuli, thereby increasing the motivational properties of drugs and of natural incentive stimuli. Consistent with this view, mice lacking D 2 -autoR display hyperactivity in novel environments and enhanced motivation to seek rewards (Bello et al., 2011) . By conferring an increased sensitivity to reward signals, a subsensitivity of D 2 -autoR functioning could biologically prime individuals to be more likely to engage in novel and varied experiences and to experience greater positive affect in situations containing reward cues. Consistent with Zald et al.'s proposal (2008) , our data thus concur with the evidence suggesting that individual differences in midbrain D 2 -autoR availability may be one neurobiological substrate of novelty-related behaviours.
In addition to differences in presynaptic function, RHAs and RLAs also showed differences in post-synaptic elements of DA transmission. ** p < 0.01, *** p < 0.001 as compared to RLA rats, using a multivariate analysis of variance followed by a LSD post hoc test. (Giorgi et al., 1997; Saigusa et al., 1999) and others showing a higher (Hooks et al., 1992; Verheij and Cools, 2007) or lower (Chefer et al., 2003) basal DA outflow in striatum of high vs. low novelty-seekers. However, the behavioural hyposensitivity of RHA to direct pre-and postsynaptic D 2 R stimulations clearly indicates that, in addition to an effect of competition with higher levels of striatal DA, the lower radioligand bindings measured in RHA vs. RLA rats are also related to lower D 2 R availabilities in striatum and SN/VTA. This is consistent with reports showing that high novelty-responsive rats have lower densities of D 2 R in dorsal striatum and in NAcc than low responders (Hooks et al., 1994; Dietz et al., 2008) . Similarly, brain imaging of [ 11 C]raclopride in humans has revealed an association between high sensation-seeking and lower D 2 R availability in striatum (Gjedde et al., 2010) to individual head-dipping scores. Altogether, our findings contribute to the evidence that low D 2 R-mediated DA signalling in striatum is critically involved in novelty-seeking and may contribute to the increased vulnerability of high novelty-seekers to addiction.
Behavioural sensitization is considered to play an important role in the acquisition and maintenance of drug addiction (Robinson and Berridge, 1993) . As observed with substance abuse in humans, the degree of sensitization in animals varies considerably from one individual to the other (Segal and Kuczenski, 1987) . Consistent with previous findings (Corda et al., 2005) , high novelty-responding RHA rats developed behavioural sensitization to repeated Amph dosing, while low novelty-responding RLAs did not. Moreover, the correlation observed across animals between individual differences in novelty-seeking and subsequent behavioural sensitization to Amph provides further support that high reactivity to novelty can predict the magnitude to which sensitization develops with subsequent Amph dosing (Piazza et al., 1989) . Although the cause of inter-individual susceptibility to behavioural sensitization is unknown, the predictive power of novelty-seeking traits in the magnitude of behavioural sensitization suggests that both entities may have a common substrate. Current evidence indicates that the site of action of Amph that is critical for the induction of behavioural sensitization lies within the midbrain (Kalivas and Weber, 1988) and likely involves a decreased sensitivity of D 2 -autoR, leading to a hyperexcitability of midbrain DA neurons (White and Wang, 1984) . This hyperexcitability would be responsible for excessive mesolimbic DA signalling and the resulting misattribution of exaggerated salience to reward-associated stimuli (Robinson and Berridge, 1993) . One mechanism that could explain the higher susceptibility of high noveltyseeker RHA rats to Amph-induced sensitization could be linked to their low density of D 2 -autoR in midbrain.
As aforementioned, novelty-seeking has already been associated with low availability of midbrain D 2 -autoR (Zald et al., 2008) and with increased levels of sensitization (Boileau et al., 2006) . It has also been proposed that low striatal D 2/3 R availabilities in both humans (Volkow et al., 2002; Lee et al., 2009 ) and rodents (Dalley et al., 2007) as well as high striatal DA levels in rodents (Piazza et al., 1991) may represent predisposing factors to compulsive drug use. Thus, there is previous literature, both in humans and rodents, linking the novelty-seeking trait, and its corollary involvement in vulnerability to addiction, to either an exaggerated DA response to stimuli or to low levels of D 2 R availability in midbrain or in striatum. However, studies so far have solely focused on either aspect of DA D 2 R-mediated signalling separately, without providing a unification of these presynaptic, synaptic and post-synaptic phenomena. To our Novelty-seeking, drug sensitization and D 2/3 R 1831 knowledge, our study is the first to bridge that gap by showing that disturbances in pre-and post-synaptic D 2 R signalling are both associated with the noveltyseeking trait and that both could actually constitute neurochemical markers of a predisposition to substance abuse.
Taken together, our results extend accumulating evidence on inverse relationships between D 2 R densities and individual differences in novelty-seeking and vulnerability to drug addiction and suggest the use of D 2 R availability as a marker of drug-prone phenotypes. Noteworthy, it is difficult to disentangle whether it is low D 2 R availability in the brain that provides a neurochemical endophenotype for novelty-seeking and predisposition to drug addiction or whether it is that high D 2 R availability confers low novelty-seeking traits and protection to addiction. In this latter respect, there is evidence indicating that targeted overexpression of striatal D 2 R reduced drug intake in rodents (Thanos et al., 2001) . Moreover, elevated social status has been associated with high D 2 R densities and appeared to protect individuals from the reinforcing effects of drug use in humans and monkeys (Morgan et al., 2002; Martinez et al., 2010) . The Swiss sublines of RHA and RLA rats are suitable animal models to investigate the influence of pharmacological and environmental manipulations aimed at increasing or decreasing D 2 R expression and function both on personality traits known to be associated with high risk for substance abuse and on drug sensitivity. Such studies may pave the way to find early intervention strategies for individuals who are at high personality risk for substance dependence. 
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